A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT

Clinical trial NCT02981446 · COMPLETED

Trial details

NCT number: NCT02981446
Sponsor: Santen Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open Angle Glaucoma or Ocular Hypertension

Start date: 2017-01-01
Primary completion: 2019-01-01
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.